Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial ...

An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of ...

First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions ...

The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice ...

John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through ...

Targeted lipid nanoparticles generate CAR NK cells in mice, showing activity against cancer and autoimmune liver disease ...

Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and why faster clinical execution will shape the next generation of medicines ...

Discover how the right excipient can support efficient processing, reliable dosing, fast dissolution and a more patient-friendly experience, and learn what galenIQ™ brings to modern sachet development ...

Novartis and Bristol Myers Squibb have paused clinical trials of their respective CD19-directed CAR T therapies in autoimmune diseases while they review safety data. Novartis halted eight studies of ...

Patients own immune cells genetically modified in the laboratory, track down the disease driving B cells, even deep within tissues. Inflammatory foci such as those seen here around the knee joints of ...

What was your biggest professional highlight of the past 12 months? We’ve seen several notable highlights over the past 18 months, but if I had to name one, it would be the approval of lisaftoclax in ...

A distinct population of CAR T cells could help predict whether products containing fewer cells than intended will still produce a therapeutic response, according to a new study. Researchers from the ...